Chilocarpus costatus
Chilocarpus costatus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Chilocarpus costatus is a botanical species that has gained scientific interest due to its potential therapeutic properties. Recent studies have focused on evaluating its biological activity against specific microbial pathogens. In particular, researchers have tested its effectiveness against the bacterium Staphylococcus epidermidis. To facilitate this investigation, chloroform extracts of the plant were prepared for experimental analysis. These findings aim to contribute to the broader understanding of the plant's medicinal potential in combating skin-associated infections.
- Synonyms
- Chilocarpus Maingayi · Chilocarpus Diepenhorstii · 3 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Chilocarpus costatus is a botanical species that is associated with a diverse array of synonymous names. Within taxonomic literature, this plant is frequently identified by the synonym Chilocarpus aurantiacus. Its classification further includes various forms, such as the specific variety known as Chilocarpus costatus var. borneensis. Researchers also encounter it under different nomenclature, including Chilocarpus cuneifolius and Chilocarpus diepenhorstii. Additionally, the name Chilocarpus maingayi serves as another recognized synonym within its complex biological identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Chilocarpus costatus is a distinct botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further belongs to the order Gentianales, showcasing its specific evolutionary lineage. As a member of the genus Chilocarpus, it occupies a unique niche in the natural world. Finally, this plant is categorized within the family Apocynaceae, completing its complex biological profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Chilocarpus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Chilocarpus costatus is a plant species characterized by its widespread presence across various tropical regions of Asia. Its distribution spans through Indo-China, including specific territories in Myanmar and Thailand. The species is also well-established within the Malesia region, finding fertile habitats across the islands of Borneo and Sumatera. Furthermore, its range extends into the Malay Peninsula, highlighting its ecological adaptability. This diverse geographical footprint underscores the significant presence of the species throughout the Southeast Asian tropics.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Chilocarpus costatus develops into a shrubby growth form that serves as a foundation for its structural development. This plant also possesses an obligatory climbing habit, requiring external support to reach its full height.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Chilocarpus costatus demonstrates significant medicinal potential through its various anti-infective activities. The chloroform extracts of this plant species exhibit good activity against the protozoan Leishmania donovani. Additionally, Chilocarpus costatus shows effective antiplasmodial properties against the chloroquine-resistant Plasmodium falciparum K1 strain. Beyond protozoa, the plant extract and its isolated compound, pinoresinol, work to increase the sensitivity of Staphylococcus epidermidis to cefotaxime. These diverse interactions highlight the plant's ability to target different infectious pathogens.
Preparations
Chilocarpus costatus is prepared as chloroform extracts to evaluate its medicinal potential against various pathogens. These specific chloroform extracts were tested for their effectiveness against Leishmania donovani and the chloroquine-resistant Plasmodium falciparum K1 strain. The study revealed that the extracts of this plant species demonstrated good antileishmanial and antiplasmodial activities. Furthermore, the research explored how the extract and its isolated compound, pinoresinol, could enhance bacterial sensitivity to antibiotics. Through this preparation method, the plant's ability to serve as a source for new anti-infective chemotypes was successfully investigated.